Health Care & Life Sciences » Biotechnology | Tiziana Life Sciences PLC

Tiziana Life Sciences PLC

Tiziana Life Sciences PLC
Stock Exchange London Stock Exchange
EPS
GBP0.05
Market Cap
GBP92.8 M
Shares Outstanding
126.93 M
Public Float
55.41 M

Profile

Address
55 Park Lane
London Greater London W1K 1NA
United Kingdom
Employees -
Website http://www.tizianalifesciences.com
Updated 07/08/2019
Tiziana Life Sciences Plc operates as a clinical stage biotechnology company that focuses on the discovery and development of drugs that treat human disease in oncology and immunology. The company was founded by Gabriele Marco Antonio Cerrone on November 4, 2013 and is headquartered in London, the United Kingdom. .

Financials

View All

Gabriele Marco Antonio Cerrone
Executive Chairman
Kunwar Shailubhai
Director, Chief Executive & Scientific Officer